Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A study on the biochemical and the morphological changes in the liver in renal transplant recipients with an evidence of the HBV and the HCV infections.

Sharma S, Gupta A, Kalhan S, Dudani S, Sharma P, Devra A.

J Clin Diagn Res. 2013 Jan;7(1):79-81. doi: 10.7860/JCDR/2012/4964.2675.

2.

Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation.

Kazi S, Prasad S, Pollak R, Holzer T, Heynen C, Fabrega AJ, Pitrak D, Layden TJ.

Dig Dis Sci. 1994 May;39(5):961-4.

PMID:
7513631
3.

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.

Delladetsima JK, Boletis JN, Makris F, Psichogiou M, Kostakis A, Hatzakis A.

Liver Transpl Surg. 1999 Jul;5(4):294-300.

4.

Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients.

Gohar SA, Khalil RY, Elaish NM, Khedr EM, Ahmed MS.

J Egypt Public Health Assoc. 1995;70(5-6):465-84.

PMID:
17214170
5.

Management of chronic viral hepatitis before and after renal transplantation.

Gane E, Pilmore H.

Transplantation. 2002 Aug 27;74(4):427-37. Review.

PMID:
12352899
6.

Long-term impact of hepatitis B, C virus infection on renal transplantation.

Lee WC, Shu KH, Cheng CH, Wu MJ, Chen CH, Lian JC.

Am J Nephrol. 2001 Jul-Aug;21(4):300-6.

PMID:
11509802
7.

Outcome of hepatitis B and C virus infection on graft function after renal transplantation.

Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.

Transplant Proc. 2005 Sep;37(7):3045-7.

PMID:
16213299
8.

A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients?

Lee PC, Hung CJ, Lin YJ, Wang JR, Jan MS, Lei HY.

Transplantation. 2002 May 27;73(10):1635-9.

PMID:
12042652
9.

Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data.

Kliem V, Burg M, Haller H, Suwelack B, Abendroth D, Fritsche L, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U.

Transplant Proc. 2008 May;40(4):909-14. doi: 10.1016/j.transproceed.2008.03.031.

PMID:
18555076
10.

Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.

Rostaing L, Izopet J, Cisterne JM, Icart J, Chabannier MH, Panicali H, Durand D.

Am J Nephrol. 1997;17(1):46-52.

PMID:
9057953
11.

[Evaluation of viral hepatitis in solid organ transplantation].

Mikolašević I, Sladoje-Martinović B, Orlić L, Milić S, Lukenda V, Župan Ž, Štimac D, Rački S.

Acta Med Croatica. 2014 Apr;68(2):151-9. Review. Croatian.

PMID:
26012153
12.

Role of molecular techniques in the detection of HBV DNA & HCV RNA among renal transplant recipients in India.

Radhakrishnan S, Abraham P, Raghuraman S, John GT, Thomas PP, Jacob CK, Sridharan G.

Indian J Med Res. 2000 Jun;111:204-11.

PMID:
10969488
13.

Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients.

Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF.

Am J Gastroenterol. 1999 Jan;94(1):159-63.

PMID:
9934748
14.

Clinicopathologic features of hepatitis C virus infection in renal allograft recipients.

Chan TM, Wu PC, Lau JY, Lai CL, Lok AS, Cheng IK.

Transplantation. 1994 Nov 15;58(9):996-1000.

PMID:
7974739
15.

Renal transplant in hepatitis B and C positive patients--a ten years experience.

Rathod JR, Sirsat RA, Shah BV.

J Assoc Physicians India. 2002 Jun;50:766-70.

PMID:
12240839
16.

Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.

Minz M, Sharma A, Das A, Chawla Y.

Transplant Proc. 2008 Sep;40(7):2386-8. doi: 10.1016/j.transproceed.2008.07.068.

PMID:
18790242
17.

Transplant-associated autoimmune mechanisms in human hepatitis C virus infection.

Zucker K, Roth D, Cirocco R, Mathew J, Carreno M, Fuller L, Karatzas T, Jin Y, Burke G, Nery J, Webb M, Tzakis A, Esquenazi V, Miller J.

J Clin Immunol. 1996 Jan;16(1):60-70.

PMID:
8926287
18.

Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters.

Fehr T, Riehle HM, Nigg L, Grüter E, Ammann P, Renner EL, Ambühl PM.

Am J Kidney Dis. 2003 Jul;42(1):193-201.

PMID:
12830472
19.

Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.

Delladetsima JK, Makris F, Psichogiou M, Kostakis A, Hatzakis A, Boletis JN.

Liver. 2001 Apr;21(2):81-8.

PMID:
11318976
20.

The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study.

Mahmoud IM, Elhabashi AF, Elsawy E, El-Husseini AA, Sheha GE, Sobh MA.

Am J Kidney Dis. 2004 Jan;43(1):131-9.

PMID:
14712436

Supplemental Content

Support Center